2025年医药包装市场前景

04 03 01Keytakeaways Delivering onsustainability initiatives Innovations in packagingand drug delivery Sustainability remains a top concern forpharmaceutical packagers, with focuson material lifecycle management andregulatory challenges and incentives. Blockbuster drugs like GLP-1 agonists and biologicsare driving interest in new pharmaceuticalpackaging solutions. 02Introduction 06 05 07Contributors Regional policies and shiftingpriorities for packaging Putting patients firstwith packaging 08References Everchanging global and regional policies areproving to be a challenge to navigate for not justpharmaceutical packagers, but the industry as awhole. Addressing gaps in patient-centredcare will be a growing priority forpharma packagers and drug deliverycompanies looking to remain relevantand competitive. Key takeaways Key takeaways1/2 Biologics demandingnew packagingsolutions for diseaseindications Regulators andlegislation mustenforce and harmonisepharmaceuticalsustainability Pharmaceuticalpackaging innovationtakes place early in thedevelopment process The rise of biologics and theirspecialised requirementsregarding cold chain andspecific delivery needs arebringing new opportunities tothe pharmaceutical packagingsector. More and more, thepharmaceutical industryis realising that to achievegoals like sustainability,patient-centricity, andunique drug packaging anddelivery solutions, packagingconsiderations must comeearlier in the developmentprocess. In order to truly establish asustainable industry, includingpharmaceutical packaging, theindustry will need harmonisationfrom regional and globalregulators to incentiviseand drive efforts towardssustainability. Key takeaways2/2 Pharma supply chainto remain increasinglycomplex, packagingincluded Drawing inspirationfrom other industriescould drive pharmapackaging innovation The pharmaceutical supplychain remains a complex web,especially with the BIOSECURE Actand tariffs affecting partnershipsacross the globe. Pharmaceuticalpackagers are not exempt fromthis, and the effects of theseshifting attitudes on future ofstrategic collaborations remainsto be seen. Industries such as cosmeticsand FMCG, where packaginginnovations have alreadybeen implemented, couldserve as guidelines for thepharmaceutical industry lookingto up their sustainability gameor meet specific drug demands. Introduction Introduction The pharmaceutical packaging industry plays a pivotalrole in the larger healthcare market, ensuring productsafety, integrity, and efficacy [1]. As the pharmaceuticalindustry contends with incoming regulations onsustainability and consumer demands for therapeuticsincluding GLP-1 agonists and innovative treatments,pharmaceutical packaging will be at the forefront of newideas and products. In 2025 and the years to come, the pharmaceuticalpackaging sector is bracing for marked changes andopportunities for all. By the end of 2025, the packagingmarket for the broader healthcare industry is expected toreach US$159 billion, with predictions putting the value atnearly US$400 billion within the next decade [1]. This Trend Report explores the biggest trends affectingthe pharmaceutical packaging sector, with a particularfocus on the therapeutics demanding innovationand creativity in delivery and packaging. Continuingdiscussions around meeting sustainability objectives andpartnership demands are also influencing the sector’sactivities in ways that are changing the industry as awhole. Innovations inpackaging anddrug delivery Innovations inpackaging anddrug delivery sustainability concerns, and drug delivery devicesgeared towards specific patient populations likegeriatric patients and accessible designs are forcingpharmaceutical companies to take their therapeuticpackaging considerations into account at the start oftheir drug development pipelines [2]. Top therapeutics demandpackaging innovation The pharmaceutical industry is seeing an unprecedentedmoment in history where consumer-driven demandsare shaping the priorities of the pharmaceutical supplychain. Pharmaceutical companies are now lookingfor packaging solutions for all kinds of innovative drugproducts to meet consumer demand [2]. Increasingdemand for certain blockbuster therapeutics, While sustainability and ESG practices are a continuingfactor driving corporate decision making, patientconsiderations are now also playing a bigger role indictating the packaging market. Now, a major driver fornew forms of packaging is the response to increasingdemand in particular therapeutics. “What we are seeing in the industry today is a focus onbio-therapeutics (biologics and biological products),”explainsAsmita Khanolkar, Senior Director at SMC Ltd.“Alot of these biological products are complex formulationswith special storage and delivery requirements. Withinjectables in mind, delivery is typically via devices andthe stability of biologics requires cold chain storage. Thisrequires a different type of packagin